Josef Smolen, MD
Medical University of Vienna
Vienna, Austria
Disclosure(s): Ananda, Immunovant, R-Pharma: Advisor or Review Panel Member (Ongoing); Chugai, UCB, Sandoz, Abbott, Astra.Zeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galapagos: Grant/Research Support (Terminated)
S. Louis Bridges, Jr, MD, PhD
Hospital for Special Surgery
New York, New York, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Gregory Gardner, MD
University of Washington
Anacortes, WA, United States
Disclosure information not submitted.
The Editor's Choice session showcases a selection of significant recent and upcoming papers that are highly relevant to rheumatologists. The discussion will focus on the key attributes that make these papers notable. Leading this session are two distinguished editors from prominent rheumatology journals. For 2025, Dr. S. Louis Bridges, editor of Arthritis & Rheumatology, and Dr. Josef Smolen, editor of Annals of Rheumatic Diseases, will serve as the moderators.